metylperon has been researched along with Schizophrenia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobo, WV; Jayathilake, K; Lee, MA; Meltzer, HY | 1 |
| Alam, R; Gadhia, S; Röhricht, F; Willis, M | 1 |
| Jayathilake, K; Meltzer, HY; Sumiyoshi, T | 3 |
| Buchkremer, G; Köhnke, MD; Lutz, U; Schott, K; Schwärzler, F; Weller, B; Wiatr, G | 1 |
| Fayyaz, G; Gavin, M; Goldman, MB; Paul, S; Pilla, RS; Wood, G; Zaheer, S | 1 |
| Bjerkenstedt, L; Gullberg, B; Härnryd, C; Sedvall, G | 1 |
| Bjerkenstedt, L; Eneroth, P; Härnryd, C; Sedvall, G | 1 |
| Bjerkenstedt, L | 1 |
| Farde, L; Halldin, C; Wiesel, FA | 1 |
| Bjerkenstedt, L; Gullberg, B; Härnryd, C | 1 |
6 trial(s) available for metylperon and Schizophrenia
| Article | Year |
|---|---|
The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
Topics: Analysis of Variance; Antipsychotic Agents; Butyrophenones; Cognition; Female; Humans; Male; Multivariate Analysis; Psychotic Disorders; Regression Analysis; Schizophrenia | 2003 |
A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Butyrophenones; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 2003 |
Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients.
Topics: Adrenocorticotropic Hormone; Adult; Anti-Inflammatory Agents; Antipsychotic Agents; Butyrophenones; Drinking; Feedback, Physiological; Female; Glucocorticoids; Hippocampus; Humans; Hydrocortisone; Hyponatremia; Male; Middle Aged; Schizophrenia; Water-Electrolyte Imbalance | 2007 |
Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women.
Topics: Adult; Butyrophenones; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Middle Aged; Piperidines; Prolactin; Receptors, Dopamine; Schizophrenia; Substance Withdrawal Syndrome; Thiothixene; Tranquilizing Agents | 1977 |
Melperone in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Butyrophenones; Diazepam; Double-Blind Method; Drug Therapy, Combination; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiothixene | 1989 |
A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward.
Topics: Adult; Antipsychotic Agents; Butyrophenones; Double-Blind Method; Female; Humans; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Therapeutic Community | 1989 |
6 other study(ies) available for metylperon and Schizophrenia
| Article | Year |
|---|---|
Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Body Mass Index; Body Weight; Butyrophenones; Clozapine; Female; Humans; Male; Schizophrenia; Time Factors | 2010 |
Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia.
Topics: Adult; Antipsychotic Agents; Butyrophenones; Clozapine; Female; Follow-Up Studies; Humans; Male; Medical Audit; Middle Aged; Off-Label Use; Prospective Studies; Quality of Life; Schizophrenia; Severity of Illness Index; Treatment Outcome; Young Adult | 2012 |
Cytochrome P450 2D6 dependent metabolization of risperidone is inhibited by melperone.
Topics: Adult; Butyrophenones; Cytochrome P-450 CYP2D6 Inhibitors; Humans; Male; Risperidone; Schizophrenia; Sleep Deprivation | 2006 |
Melperone in the treatment of neuroleptic-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Brief Psychiatric Rating Scale; Butyrophenones; Drug Resistance; Female; Humans; Male; Schizophrenia | 2001 |
Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women.
Topics: Butyrophenones; Diazepam; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Paranoid Disorders; Piperidines; Prolactin; Schizophrenia; Therapeutic Equivalency; Thiothixene | 1979 |
Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET.
Topics: Adult; Antipsychotic Agents; Butyrophenones; Female; Humans; Male; Prolactin; Psychotic Disorders; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Tomography, Emission-Computed | 1989 |